Additionally, these drugs are to be avoided in patients with a history of thyroid cancer, either themselves or in the family
A few days of unpleasant bouts on the toilet while adjusting to GLP-1s are tolerable, but you should be acutely mindful of more serious side effects : Intense stomach pains, even while not on the toilet Dehydration, presented as altered urination, light-headedness, or fatigue Fever Rememberwhile unpleasant, diarrhea is usually manageable at home and does not impact 100% of people taking Ozempic, Wegovy, or Rybelsus
Key Takeaways Starting dose: 2 mg once weekly for 4 weeks Titration pace: Increase every 4 weeks: 2 4 8 12 mg Maximum dose: 12 mg weekly (Phase 2/3 clinical trial protocol) Total ramp-up: ~16 weeks to reach maximum dose Mechanism: Triple agonist (GLP-1 + GIP + Glucagon), the only triple-agonist in late-stage trials Weight loss: Up to 24.2% at 48 weeks (Phase 2) and 28.7% at 68 weeks (Phase 3 TRIUMPH-4) GLP-3 Retatrutide Dosage Chart Free printable reference chart showing the retatrutide (GLP-3) clinical trial titration schedule from 2 mg to 12 mg weekly
Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis
What happens when you stop taking retatrutide